Skip to main content

Advertisement

SpringerLink
Log in

Completion of axillary dissection for a positive sentinel node: Necessary or not?

  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Sentinel node excision has been widely accepted as the initial surgical step for evaluating the axilla for metastatic breast cancer. When the nodes are positive, the standard of care is to complete the axillary node dissection, a more extended procedure that carries an increased risk for morbidity. This article reviews data from sentinel lymph node trials, case series reports of outcomes when axillary node dissection was not performed in the setting of positive sentinel nodes, models for predicting the status of nonsentinel nodes, and the morbidity associated with axillary operations. Despite an approximate 10% false-negative rate, early results indicate that there is a much lower local recurrence rate after sentinel node excision alone and that systemic therapy may sterilize the axilla. In selected patients, it may be appropriate to forgo an axillary node dissection, although there are no randomized clinical trial data to support or refute this suggestion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Krag DN, Anderson SJ, Julian TB, et al.: Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet 2007, 8:881–888.

    Article  CAS  Google Scholar 

  2. Julian TB, Fourchotte V, Anderson SJ, et al.: Predictive factors for which a breast cancer sentinel lymph node biopsy can be avoided [abstract #48]. Ann Surg Oncol 2008, 15(Suppl 2):16.

    Google Scholar 

  3. Bergkvist L, de Boniface J, Jösson PE, et al.: Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study. Ann Surg 2008, 247:150–156.

    Article  PubMed  Google Scholar 

  4. van der Ploeg IM, Kroon BB, Antonini N, et al.: Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration. Ann Surg Oncol 2008, 15:1025–1031.

    Article  PubMed  Google Scholar 

  5. van der Ploeg IM, Nieweg OE, vanRijk MC, et al.: Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature. Eur J Surg Oncol 2008, April 10 [Epub ahead of print].

  6. Clarke M, Collins R, Darby S, et al.: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet 2005, 366:2087–2106.

    PubMed  CAS  Google Scholar 

  7. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al.: A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003, 10:1140–1151.

    Article  PubMed  Google Scholar 

  8. Lambert LA, Ayers GD, Hwang RF, et al.: Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol 2006, 13:310–320.

    Article  PubMed  Google Scholar 

  9. Alran S, DeRycke Y, Fourchotte V, et al.: Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol 2007, 14:2195–2201.

    Article  PubMed  Google Scholar 

  10. Kohrt HE, Olshen RA, Bermas HR, et al.: New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive beast cancer patients. BMC Cancer 2008, 8:66.

    Article  PubMed  Google Scholar 

  11. Zakaria S, Pantvaidya G, Reynolds CA, et al.: Sentinel node positive breast cancer patients who do not undergo axillary dissections: are they different? Surgery 2008, 143:641–647.

    Article  PubMed  Google Scholar 

  12. Hwang RF, Gonzalez-Angulo AM, Yi M, et al.: Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer 2007, 110:723–730.

    Article  PubMed  Google Scholar 

  13. Park J, Fey JV, Naik AM, et al.: A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with use of a multivariate nomogram. Ann Surg 2007, 245:462–468.

    Article  PubMed  Google Scholar 

  14. Takei H, Suemasu K, Kurosumi M, et al.: Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer. Breast Cancer 2007, 14:16–24.

    Article  PubMed  Google Scholar 

  15. Lucci A, McCall LM, Beitsch PD, et al.: Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 2007, 25:3657–3663.

    Article  PubMed  Google Scholar 

  16. Olson JA, McCall LM, Beitsch P, et al.: Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011. J Clin Onc 2008, 26:3530–3535.

    Article  Google Scholar 

  17. Husen M, Paaschburg B, Flyger HL: Two-step axillary operation increases risk of arm morbidity in breast cancer patients. Breast 2006, 15:620–628.

    Article  PubMed  CAS  Google Scholar 

  18. Langer I, Guller U, Berclaz G, et al.: Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 2007, 245:452–461.

    Article  PubMed  Google Scholar 

  19. Rivers AK, Griffith KA, Hunt KK, et al.: Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node. Ann Surg Oncol 2006, 13:36–44.

    Article  PubMed  Google Scholar 

  20. Fisher B, Jeong JH, Anderson S, et al.: Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy and total mastectomy followed by irradiation. N Engl J Med 2002, 347:567–575.

    Article  PubMed  Google Scholar 

  21. Veronesi U, Orecchia R, Zurrida S, et al.: Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy. Ann Oncol 2005, 16:383–388.

    Article  PubMed  CAS  Google Scholar 

  22. Louis-Sylvestre C, Clough K, Asselain B, et al.: Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Onc 2004, 22:97–101.

    Article  Google Scholar 

  23. Lyman GH, Giuliano AE, Somerfield MR, et al.: American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005, 23:7703–7720.

    Article  PubMed  Google Scholar 

  24. Rastogi P, Anderson SJ, Bear HD, et al.: Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol 2008, 26:778–785.

    Article  PubMed  Google Scholar 

  25. Bear HD, Anderson S, Brown A, et al.: The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocal B-27. J Clin Oncol 2003, 21:4165–4173.

    Article  PubMed  CAS  Google Scholar 

  26. Khan A, Sabel MS, Nees A, et al.: Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy. Ann Surg Oncol 2005, 12:697–704.

    Article  PubMed  Google Scholar 

  27. Newman EA, Sabel MS, Nees AV, et al.: Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol 2007, 14:2946–2952.

    Article  PubMed  Google Scholar 

  28. Cowher MS, Erb KM, Poller WR, et al.: Ultrasound guided axillary lymph node biopsy: changes from fine needle aspirations to core needle biopsy. Poster presented at the Ninth Annual Meeting of the American Society of Breast Surgeons. New York, NY; April 20–May 4, 2008.

  29. Cowher MS, Pereira TC, Erb KM, et al.: Sentinel lymph node intra operative imprint cytology compared to final histologic diagnosis: a review. Poster presented at the 32nd Annual Symposium of the American Society of Breast Disease. San Diego, CA; April 10–12, 2008.

  30. Julian TB, Blumencranz P, Deck K, et al.: Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer. J Clin Oncol 2008, 26:3338–3345.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Allegheny General Hospital, 320 East North Avenue, Pittsburgh, PA, 15213, USA

    Kathleen M. Erb

Authors
  1. Kathleen M. Erb
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas B. Julian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kathleen M. Erb.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Erb, K.M., Julian, T.B. Completion of axillary dissection for a positive sentinel node: Necessary or not?. Curr Oncol Rep 11, 15–20 (2009). https://doi.org/10.1007/s11912-009-0004-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-009-0004-8

Keywords

Search

Navigation